Is your newest brand on track to receive regulatory approval in the next year? Want to make a big splash with local and regional media? Need perspective to reach key physicians and patients? We work with you to devise a global strategy to position your product for launch success. Our in-country expert partners can work with you to make sure your global campaign is implemented successfully in-country.
“We work in tandem with your product launch team to prioritize audiences and ensure maximum recognition of your product.”
“As health care costs continue to rise, developing a value narrative along with establishing efficacy and safety will be critical for all future launches in the United States and globally.”
The latest from our blog
Read our latest posts on product launch strategy.
Despite being somewhat averse to speculation, Guess What’s editorial board asked me to write about trends for 2017. I leave here my 12 guesses.read more
Here at GLOBALHealthPR, we go to all ends of the earth to deliver our clients recipes for successful global and regional communications programmes. With offices in more than 40 countries, we know how to find the right mix of local insights and ingredients in order satisfy the unique tastes and needs of each programme.
In the spirit of the holiday season, we’re sharing some of the traditional recipes that are enjoyed in our local markets around this time of the year, delivered by our expert agency partners. Bon Appetite!read more
I’ve been in Sydney, Australia for just over a week now as a part of the GLOBALHealthPR® Professional Exchange Program. While I’ve done “heaps” of touristy things like check out sweeping views of the city from the Sydney Tower Eye, watched surfers catch some waves at Manly Beach and hung out with koalas at the Wild Life Sydney Zoo, I’ve also gotten a taste of what it’s like to live as a local Aussie. Here are a few things about working with colleagues at our partner agency Team VIVA! that I wanted to share:read more
Today’s post comes to us from Philipp Dieterich, Strategy Expert at GLOBALHealthPR Germany partner, fischerAppelt.
Earlier this year, the German pharma association FSA implemented the Transparency Code, which means that for the first time all pharmaceutical companies in Germany have to publish all monetary contributions they have paid to medical institutions, doctors and other partners throughout the previous year. Technically speaking, this is not a challenging request. However, companies that carry out their duty and publish those numbers let go of the opportunity to establish a new compliance culture and shape communication around it.read more
Recent changes to medicinal marijuana laws and regulations globally have expanded opportunities for medical research and patient care.
These actions are part of a broader global movement of governments and advocates to recognise the potential medicinal benefits of marijuana, which has long been considered solely a harmful recreational drug. These purported medical benefits include aiding in the treatment of epilepsy, PTSD, chronic pain and more.
Here we present three examples of GLOBALHealthPR member countries – Australia, Canada and the United States – that are tackling the legislative issues surrounding the use of medical marijuana.read more
For most individuals, the prescriber-patient relationship ends when the prescriber rips off a paper with the patient’s written prescription. As a patient, the moment you see the bottom of your prescription bottle, you know it’s time to take a trip down to the pharmacy to restock the pills. Weeks, months, and even years have passed by and you’re in a cycle of refilling your prescription, with poor communication between you and your prescriber. You may not feel the necessity to call up your prescriber because you feel fine, right? If you don’t experience life-threatening side effects, you must think you’re doing ok.read more